Glenmark Therapeutics Inc. USA has introduced its over-the-counter (OTC) Adapalene Gel USP, 0.1% in a brand-new pump-pack format. This product features the same active ingredient and strength found in Differin Gel, 0.1%.

According to Nielsen syndicated data for the latest 52-week period ending September 5, 2026, the Differin Gel, 0.1% (OTC) market achieved annual sales of approximately $45.8 million.

Commenting on the launch, Marc Kikuchi, President & Business Head, North America, said, "The introduction of Adapalene Gel USP, 0.1% (OTC) in a new pump pack enhances consumer experience by offering a convenient and easy to use dispensing option while further strengthening our growing U.S. dermatology portfolio. This launch reflects our commitment to delivering high quality and affordable healthcare solutions that meet evolving consumer needs."